company background image
PHAR

Pharma DekoNGSE:PHARMDEKO Stock Report

Market Cap

₦564.0m

7D

0%

1Y

73.3%

Updated

21 Oct, 2021

Data

Company Financials
PHARMDEKO fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

PHARMDEKO Overview

Pharma Deko Plc engages in manufacturing, packaging, and marketing pharmaceutical and consumer products in Nigeria.

Price History & Performance

Summary of all time highs, changes and price drops for Pharma Deko
Historical stock prices
Current Share Price₦2.60
52 Week High₦1.09
52 Week Low₦2.85
Beta0.079
1 Month Change60.49%
3 Month Change114.88%
1 Year Change73.33%
3 Year Change54.76%
5 Year Change60.49%
Change since IPO-10.65%

Recent News & Updates

Shareholder Returns

PHARMDEKONG BeverageNG Market
7D0%7.2%1.4%
1Y73.3%0.6%41.3%

Return vs Industry: PHARMDEKO exceeded the NG Beverage industry which returned -4.9% over the past year.

Return vs Market: PHARMDEKO exceeded the NG Market which returned 40.4% over the past year.

Price Volatility

Is PHARMDEKO's price volatile compared to industry and market?
PHARMDEKO volatility
PHARMDEKO Beta0.079
Industry Beta0.68
Market Beta1

Stable Share Price: PHARMDEKO is more volatile than 90% of NG stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: PHARMDEKO's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of NG stocks.

About the Company

FoundedEmployeesCEOWebsite
196263Isola Olukayodehttps://www.pharmadekoplc.com

Pharma Deko Plc engages in manufacturing, packaging, and marketing pharmaceutical and consumer products in Nigeria. It operates through three segments: Pharma, Consumer, and Contract. The company offers pharmaceutical products, such as Vitacee syrups and drops, Pharmadec syrups and drops, Brett mouthwash, Hexedene oral care medication, Parkalin range of cough syrup, Parkaling Pediatrics, Revitone Blood Tonic, Salins Liniment, Antasil tablets, Omepraz capsules, Sparxin, Amoquin and Garlic tablets, Pidiclox dry powder and capsules, Anuproct suppository, and Parkaprim tablets and suspension, as well as paracetamol under the Phardol Drops brand.

Pharma Deko Fundamentals Summary

How do Pharma Deko's earnings and revenue compare to its market cap?
PHARMDEKO fundamental statistics
Market Cap₦564.02m
Earnings (TTM)-₦325.21m
Revenue (TTM)₦460.84m

1.2x

P/S Ratio

-1.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PHARMDEKO income statement (TTM)
Revenue₦460.84m
Cost of Revenue₦405.33m
Gross Profit₦55.51m
Expenses₦380.71m
Earnings-₦325.21m

Last Reported Earnings

Dec 31, 2020

Next Earnings Date

n/a

Earnings per share (EPS)-1.50
Gross Margin12.05%
Net Profit Margin-70.57%
Debt/Equity Ratio1.4%

How did PHARMDEKO perform over the long term?

See historical performance and comparison

Valuation

Is Pharma Deko undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: PHARMDEKO (NGN2.6) is trading below our estimate of fair value (NGN55.85)

Significantly Below Fair Value: PHARMDEKO is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: PHARMDEKO is unprofitable, so we can't compare its PE Ratio to the African Beverage industry average.

PE vs Market: PHARMDEKO is unprofitable, so we can't compare its PE Ratio to the NG market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate PHARMDEKO's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: PHARMDEKO is good value based on its PB Ratio (0.6x) compared to the NG Beverage industry average (0.9x).


Future Growth

How is Pharma Deko forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

21.9%

Forecasted Food, Beverage & Tobacco industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Pharma Deko has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Pharma Deko performed over the past 5 years?

-56.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: PHARMDEKO is currently unprofitable.

Growing Profit Margin: PHARMDEKO is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: PHARMDEKO is unprofitable, and losses have increased over the past 5 years at a rate of 56.9% per year.

Accelerating Growth: Unable to compare PHARMDEKO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PHARMDEKO is unprofitable, making it difficult to compare its past year earnings growth to the Beverage industry (19.7%).


Return on Equity

High ROE: PHARMDEKO has a negative Return on Equity (-32.97%), as it is currently unprofitable.


Financial Health

How is Pharma Deko's financial position?


Financial Position Analysis

Short Term Liabilities: PHARMDEKO's short term assets (NGN353.3M) do not cover its short term liabilities (NGN1.0B).

Long Term Liabilities: PHARMDEKO's short term assets (NGN353.3M) exceed its long term liabilities (NGN18.1M).


Debt to Equity History and Analysis

Debt Level: PHARMDEKO's debt to equity ratio (1.4%) is considered satisfactory.

Reducing Debt: PHARMDEKO's debt to equity ratio has reduced from 5.5% to 1.4% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if PHARMDEKO has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if PHARMDEKO has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Dividend

What is Pharma Deko current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate PHARMDEKO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate PHARMDEKO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if PHARMDEKO's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if PHARMDEKO's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: PHARMDEKO is not paying a notable dividend for the NG market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of PHARMDEKO's dividend in 3 years as they are not forecast to pay a notable one for the NG market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Isola Olukayode

no data

Tenure

Mr. Isola Oluwole Olukayode serves as Managing Director at Pharma-Deko Plc and serves as Director since November 12, 2020 and served as Acting General Manager of Production Consumer/Contract and Acting Gen...


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Pharma Deko Plc's employee growth, exchange listings and data sources


Key Information

  • Name: Pharma Deko Plc
  • Ticker: PHARMDEKO
  • Exchange: NGSE
  • Founded: 1962
  • Industry: Soft Drinks
  • Sector: Food, Beverage & Tobacco
  • Market Cap: ₦564.022m
  • Shares outstanding: 216.93m
  • Website: https://www.pharmadekoplc.com

Number of Employees


Location

  • Pharma Deko Plc
  • Plot C1/1
  • Agbara Industrial Estate
  • Agbara
  • Nigeria

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/21 20:59
End of Day Share Price2021/10/21 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.